This compound is a deuterium-labeled derivative of agomelatine, used as an active pharmaceutical ingredient in the production of reference standards and impurities for pharmaceutical research.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
6-fluoro-3-hydroxypyrazine-2-carboxylic acid
pharmaceutical raw material
Dimepranol
pharmaceutical raw material
Tilmicosin
pharmaceutical raw material
Acetic acid--histidylseryl-alpha-aspartylglycylthreonylphenylalanylthreonylseryl-alpha-glutamylleucylserylarginylleucylarginyl-alpha-aspartylserylalanylarginylleucylglutaminylarginylleucylleucylglutaminylglycylleucylvalinamide (1/1)
pharmaceutical raw material
Agomelatine
pharmaceutical raw material
Agomelatine-d3 (acetamide-2,2,2-d3)
pharmaceutical raw material
Agomelatine D6
pharmaceutical raw material
N-[1,1,2,2-tetradeuterio-2-(7-methoxynaphthalen-1-yl)ethyl]acetamide
YJYPHIXNFHFHND-LZMSFWOYSA-N
[2H]C([2H])(C1=CC=CC2=C1C=C(C=C2)OC)C([2H])([2H])NC(=O)C
—
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.